Dynamic Changes of Post-Ischemic Hepatic Microcirculation Improved by a Pre-Treatment of Phosphodiesterase-3 Inhibitor, Milrinone

Journal of Surgical Research

Volumn 136, Issue 2, 2006, Pages 209-218

  Kume, Makoto ^a,b,c   Banafsche, Ramin ^a   Yamamoto, Yuzo ^b,c   Yamaoka, Yoshio ^c   Nobiling, Rainer ^a   Gebhard, Martha Maria ^a   Klar, Ernst ^a,d  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

cyclic AMP; ischemia reperfusion injury; ischemic pre conditioning; microcirculation; phosphodiesterase inhibitor

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALANINE AMINOTRANSFERASE; CYCLIC AMP; LACTATE DEHYDROGENASE; LIVER ENZYME; MILRINONE; PHOSPHODIESTERASE III INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ISCHEMIA; ISCHEMIC PRECONDITIONING; LIVER; LIVER ISCHEMIA; MALE; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RAT STRAIN; STATISTICAL SIGNIFICANCE;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; BLOOD PRESSURE; CELL COMMUNICATION; CELL SURVIVAL; CYCLIC AMP; CYCLIC GMP; ENDOTHELIAL CELLS; HEART RATE; HEMATOCRIT; ISCHEMIC PRECONDITIONING; LEUKOCYTES; LIVER; LIVER CIRCULATION; LIVER TRANSPLANTATION; MALE; MICROCIRCULATION; MICROSCOPY, VIDEO; MILRINONE; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, WISTAR; REPERFUSION INJURY; VENULES;

EID: 33750935838     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.05.038     Document Type: Article

References (53)

1. Serracino-Inglott F., Habib N.A., and Mathie R.T. Hepatic ischemia-reperfusion injury. Am J Surg 181 (2001) 160
2. Selzner N., Rudiger H., Graf R., and Clavien P.-A. Protective strategies against ischemic injury of the liver. Gastroenterology 125 (2003) 917
3. Carini R., and Albano E. Recent insights on the mechanisms of liver preconditioning. Gastroenterology 125 (2003) 1480
4. Clavien P.-A., Yadav S., Sindram D., and Bentley R.C. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 232 (2000) 155
5. Glanemann M., Vollmar B., Nüssler A.K., Schaefer T., Neuhaus P., and Menger M.D. Ischemic preconditioning protects from hepatic ischemia/reperfusion-injury by preservation of microcirculation and mitochondrial redox-state. J Hepatol 38 (2003) 59
6. Howell J.G., Zibari G.B., Brown M.F., et al. Both ischemic and pharmacological preconditioning decrease hepatic leukocyte/endothelial cell interactions. Transplantation 69 (2000) 300
7. Sawaya Jr. D.E., Brown M., Minardi A., et al. The role of ischemic preconditioning in the recruitment of rolling and adherent leukocytes in hepatic venules after ischemia/reperfusion. J Surg Res 85 (1999) 163
8. Peralta C., Hotter G., Closa D., Gelpí E., Bulbena O., and Roselló-Catafau J. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: Role of nitric oxide and adenosine. Hepatology 25 (1997) 934
9. Peralta C., Hotter G., Closa D., et al. The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A2 receptors. Hepatology 29 (1999) 126
10. Nakayama H., Yamamoto Y., Kume M., et al. Pharmacological stimulation of adenosine A2 receptor supplants ischemic preconditioning in providing ischemic tolerance in rat livers. Surgery 126 (1999) 945
11. Olah M.E., and Stiles G.L. The role of receptor structure in determining adenosine receptor activity. Pharmacol Ther 85 (2000) 55
12. Arai M., Thurman R.G., and Lemasters J.J. Contribution of adenosine A2 receptors and cyclic adenosine monophosphate to protective ischemic preconditioning of sinusoidal endothelial cells against storage/reperfusion injury in rat livers. Hepatology 32 (2000) 297
13. Minor T., Akbar S., and Yamamoto Y. Adenosine A2 receptor stimulation protects the predamaged liver from cold preservation through activation of cyclic adenosine monophosphate-protein kinase A pathway. Liver Transpl 6 (2000) 196
14. Beavo J.A. Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms. Physiol Rev 75 (1995) 725
15. Torphy T.J. Phosphodiesterase isozymes: Molecular targets for novel antiasthma agents. Am J Respir Crit Care Med 157 (1998) 351
16. Dundore R.L., Habeeb P.G., Pratt P.F., Becker L.T., Cals D.M., and Buchholz R.A. Differential hemodynamic responses to selective inhibitors of cyclic nucleotide phosphodiesterases in conscious rats. J Cardiovasc Pharmacol 19 (1992) 937
17. Kobayashi T., Sugawara Y., Ohkubo T., Imamura H., and Makuuchi M. Effects of amrinone on hepatic ischemia-reperfusion injury in rats. J Hepatol 37 (2002) 31
18. Ishikawa H., Jin M.B., Ogata T., et al. Role of cyclic nucleotides in ischemia and reperfusion injury of canine livers. Transplantation 73 (2002) 1041
19. Ikegami T., Nishizaki T., Hiroshige S., Ohta R., Yanaga K., and Sugimachi K. Experimental study of a type 3 phosphodiesterase inhibitor on liver graft function. Br J Surg 88 (2001) 59
20. Ichioka S., Nakatsuka T., Sato Y., Shibata M., Kamiya A., and Harii K. Amrinone, a selective phosphodiesterase III inhibitor, improves microcirculation and flap survival: A comparative study with prostaglandin E1. J Surg Res 75 (1998) 42
21. Zapletal C., Maksan S.M., Lehmann T., et al. Ischemic Preconditioning improves liver microcirculation after ischemia/reperfusion. Transplant Proc 31 (1999) 3260
22. Post S., Rentsch M., Gonzalez A.P., Palma P., Otto G., and Menger M.D. Effects of Carolina rinse and adenosine rinse on microvascular perfusion and intrahepatic leukocyte-endothelium interaction after liver transplantation in the rat. Transplantation 55 (1993) 972
23. Müller J.M., Vollmar B., and Menger M.D. Pentoxifylline reduces venular leukocyte adherence ("reflow paradox") but not microvascular "no reflow" in hepatic ischemia/reperfusion. J Surg Res 71 (1997) 1
24. Marzinzig M., Nussler A.K., Stadler J., et al. Improved methods to measure end products of nitric oxide in biological fluids: Nitrite, nitrate, and s-nitrosothiols. Nitric Oxide 1 (1997) 177
25. Hortelano S., Genaro A.M., and Boscá L. Phorbol esters induce nitric oxide synthase activity in rat hepatocytes. Antagonism with the induction elicited by lipopolysaccharide. J Biol Chem 267 (1992) 24937
26. Roth E., Steininger R., Winkler S., Längle F., Grünberger T., Függer R., and Mühlbacher F. L-arginine deficiency after liver transplantation as an effect of arginase efflux from the graft. Influence on nitric oxide metabolism. Transplantation 57 (1994) 665
27. Smail N., Catania R.A., Wang P., Gioffi W.G., Bland K.I., and Chaudry I.H. The organs responsible for increased nitric oxide production after trauma-hemorrhage resuscitation. Arch Surg 133 (1998) 399
28. Ally A., and Park G. Rapid determination of creatine, phosphocreatine, purine bases and nucleotides (ATP, ADP, AMP, GTP, GDP) in heart biopsies by gradient ion-pair reversed-phase liquid chromatography. J Chromatogr 575 (1992) 19
29. Hatano E., Tanaka A., Iwata S., et al. Induction of endotoxin tolerance in transgenic mouse liver expressing creatine kinase. Hepatology 24 (1996) 663
30. Atkinson D.E. The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Biochemistry 7 (1968) 4030
31. Kume M., Yamamoto Y., Saad S., et al. Ischemic preconditioning of the liver in rats: Implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. J Lab Clin Med 128 (1996) 251
32. Tomita T., Sawa M., Munakata T., Tanaka K., and Kasai S. The beneficial effect of dibutyryl cyclic adenosine monophosphate on warm ischemic injury of the rat liver induced by cardiac arrest. Transplantation 62 (1996) 167
33. Suttorp N., Weber U., Welsch T., and Schudt C. Role of phosphodiesterases in the regulation of endothelial permeability in vitro. J Clin Invest 91 (1993) 1421
34. Watanabe T., Satoo H., Kohara K., et al. Orthovanadate stimulates cAMP phosphodiesterase 3 activity in isolated rat hepatocytes through mitogen-activated protein kinase activation dependent on cAMP-dependent protein kinase. Biol Pharm Bull 27 (2004) 789
35. Feijge M.A.H., Ansink K., Vanschoonbeek K., and Heemskerk J.W.M. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3. Biochem Pharmacol 67 (2004) 1559
36. Kitai T., Tanaka A., Tokuka A., Tanaka K., Yamaoka Y., Ozawa K., and Hirao K. Changes in the hepatic oxygenation state during hemorrhage and following epinephrine or dextran infusion as assessed by near-infrared spectroscopy. Circ Shock 41 (1993) 197
37. Comerford K.M., Lawrence D.W., Synnestvedt K., Levi B.P., and Colgan S.P. Role of vasodolator-stimulated phosphoprotein in PKA-induced changes in endothelial junction permeability. FASEB J 16 (2002) 583
38. Schafer A., Burkhardt M., Vollkommer T., et al. Endothelium-dependent and -independent relaxation and VASP serines 157/239 phosphorylation by cyclic nucleotide-elevating vasodilators in rat aorta. Biochem Pharmacol 65 (2003) 397
39. Srivastava R.K., Srivastava A.R., Korsmeyer S.J., Nesterova M., Cho-Chung Y.S., and Longo D.L. Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol Cell Biol 18 (1998) 3509
40. Han J.-D., and Rubin C.S. Regulation of cytoskeleton organization and paxillin dephosphorylation by cAMP. Studies on murine Y1 adrenal cells. J Biol Chem 271 (1996) 29211
41. Qiao J., Huang F., and Lum H. PKA inhibits RhoA activation: A protection mechanism against endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 284 (2003) L972
42. Menger M.D., Richter S., Yamauchi J., and Vollmar B. Role of microcirculation in hepatic ischemia/reperfusion injury. Hepatogastroenterology 2 Suppl (1999) 1452
43. Sim D.S., Merrill-Skoloff G., Furie B.C., Furie B., and Flaumenhaft R. Initial accumulation of platelets during arterial thrombus formation in vivo is inhibited by elevation of basal cAMP levels. Blood 103 (2004) 2127
44. Takei K., Tokuyama K., Kato M., and Morikawa A. Role of cyclic adenosine monophosphate in reducing superoxide anion generation in guinea pig alveolar macrophages. Pharmacology 57 (1998) 1
45. Derian C.K., Santulli R.J., Rao P.E., Solomon H.F., and Barrett J.A. Inhibition of chemotactic peptide-induced neutrophil adhesion to vascular endothelium by cAMP modulators. J Immunol 154 (1995) 308
46. Rahman A., Anwar K.N., Minhajuddin M., et al. cAMP targeting of p38 MAP kinase inhibits thrombin-induced NF-kappaB activation and ICAM-1 expression in endothelial cells. Am J Physiol Lung Cell Mol Physiol 287 (2004) L1017
47. Zhai Y., Shen X.-D., O'Connell R., et al. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 173 (2004) 7115
48. Vajdová K., Heinrich S., Tian Y., Graf R., and Clavien P.-A. Ischemic preconditioning and intermittent clamping improve murine hepatic microcirculation and Kupffer cell function after ischemic injury. Liver Transplant 10 (2004) 520
49. Nakano H., Kuzume M., Namatame K., Yamaguchi M., and Kumada K. Efficacy of intraportal injection of Anti-ICAM-1 monoclonal antibody against liver cell injury following warm ischemia in the rat. Am J Surg 170 (1995) 64
50. Kopperud R., Krakstad C., Selheim F., and Doskeland S.O. cAMP effector mechanisms. Novel twists for an 'old' signaling system. FEBS Lett 546 (2003) 121
51. Katsuragi K., Takemura S., Minamiyama Y., et al. Combined use of adenosine and amrinone inhibits reperfusion injury of rat liver. Pathophysiology 8 (2001) 29
52. Varadarajan R., Golden-Mason L., Yound L., et al. Nitric oxide in early ischemia reperfusion injury during human orthotopic liver transplantation. Transplantation 78 (2004) 250
53. Rolland F., Winderickx J., and Thevelein J.M. Glucose-sensing mechanisms in eukaryotic cells. TRENDS in Biochem. Science 26 (2001) 310